Share Your Research, Maximize Your Social Impacts
DYSLIPIDEMIA IN PATIENTS WITH CHRONIC KIDNEY DISEASE
Journal: Ukrainian Journal of Nephrology and Dialysis (Vol.2, No. 42)Publication Date: 2014-05-30
Authors : O. M. Loboda; I. O. Dudar;
Page : 50-61
Keywords : chronic kidney disease; progression; cardiovascular disease; dyslipidemia; lipid-lowering therapy; statins.;
Source : Download
Find it from : Google Scholar
Abstract
Data about lipid disorders at different stages of chronic kidney disease (CKD), including those on dialysis are presented in the review. The possible influence of dyslipidemia on the progression of CKD, as well as the onset and progression of cardiovascular complications in patients with CKD are discussed. The questions of lipid-lowering therapy use, including statins, in patients with CKD on dialysis and predialysis, are disclosed.
Other Latest Articles
- PLASMID-INDUCED MECHANISMS OF ANTIBIOTIC RESISTANCE IN URINARY TRACT INFECTIONS
- SPECTRUM OF MICROFLORA IN URINE OF PATIENTS WITH CHRONIC RECURRENT PYELONEPHRITIS (THE TEN YEARS FOLLOWING-UP)
- THE PREDICTORS OF HOSPITALIZATION IN HEMODIALYSIS PATIENTS
- EARLYDIAGNOSIS OFINTRARENAL BLOOD FLOW DISORDERSIN PATIENTS WITH ESSENTIAL ARTERIAL HYPERTENSION
- ASSOCIATION OF ADSORPTION-RHEOLOGICAL PROPERTIES OF URINE IN GLOMERULONEPHRITIS WITH MORPHOLOGICAL CHANGES OF RENAL STRUCTURES IN PATIENTS WITH HEMORRHAGIC VASCULITIS
Last modified: 2018-09-13 20:03:50